UC San Diego Pharmacy (Pharm.D.) Class to Graduate on June 2

 

May 29, 2007  |  

Skaggs School of Pharmacy and Pharmaceutical Sciences is Southern California’s only Public Pharmacy School

Trained to meet the needs of patients, and to become leaders in drug development and delivery in the 21st-century, 23 students will graduate from the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego (UCSD) at a ceremony held at the Price Center on Saturday, June 2.  The 14 women and nine men, comprising the second graduating class of the School that was founded in 2002, will receive their Doctor of Pharmacy degrees at 10 a.m.

Guests will include keynote speaker J. Lyle Bootman, Ph.D., Dean of College of Pharmacy, and professor of pharmacy, medicine and public health at the University of Arizona.  Bootman is executive director of the university’s Center for Health Outcomes and PharmacoEconomomic Research, one of the first such centers in the world.  He is an elected member of the Institute of Medicine of the National Academies, and currently serves on its Board of Health Care Services.

Bootman will be joined by UCSD Chancellor Marye Anne Fox; David Brenner, M.D., UCSD Vice Chancellor for Health Sciences and Dean of the School of Medicine; Palmer W. Taylor, Ph.D., founding dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences in addressing the graduates.

Fourteen of the graduates received their undergraduate degrees from University of California campuses.  They are commencing to a wide variety of careers – most staying in California, which has one of the nation’s largest shortages of practicing pharmacists.

Many are going on to clinical residencies to receive the additional specialized training required for hospital pharmacy, health system providers and academic positions.

 # # #

Contact: Jacqueline Carr, (619) 543-6163, jcarr@ucsd.edu

 




Media Contact

Share This Article


Related News

6/15/2017
NASA has selected Alan Hargens, PhD, professor of orthopedic surgery at UC San Diego School of Medicine, to receive a 2017 Distinguished Public Service Medal.
6/15/2017
University of California San Diego School of Medicine has entered a five-year strategic partnership with Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnso ...
6/9/2017
Radiation therapy (RT) using high-energy particles is a common and critical component in successfully treating patients with brain tumors but it is also associated with significant adverse effects. In ...
6/7/2017
Lesions of the appendix are being over diagnosed as invasive cancer, report University of California San Diego School of Medicine researchers in a paper published June 7 in the journal PLOS ONE.



Follow Us